Skip to main content
. 2020 Nov 27;12:1758835920975353. doi: 10.1177/1758835920975353

Figure 3.

Figure 3.

The incidence of grade ⩾3 irAEs of different retreatment regimens. Note that the bubble size indicates the sample size of each study.

irAEs, immune-related adverse events; NSCLC, non-small cell lung cancer.